CYP4F2 genetic variant alters required warfarin dose
Top Cited Papers
Open Access
- 15 April 2008
- journal article
- Published by American Society of Hematology in Blood
- Vol. 111 (8) , 4106-4112
- https://doi.org/10.1182/blood-2007-11-122010
Abstract
Warfarin is an effective, commonly prescribed anticoagulant used to treat and prevent thrombotic events. Because of historically high rates of drug-aKeywords
This publication has 35 references indexed in Scilit:
- Randomized Trial of Genotype-Guided Versus Standard Warfarin Dosing in Patients Initiating Oral AnticoagulationCirculation, 2007
- Genetic-based dosing in orthopedic patients beginning warfarin therapyBlood, 2007
- Replicating genotype–phenotype associationsNature, 2007
- Identifying the genotype behind the phenotype: a role model found inVKORC1and its association with warfarin dosingPharmacogenomics, 2007
- Evaluation of Genetic Factors for Warfarin Dose PredictionClinical Medicine & Research, 2007
- Effect ofVKORC1Haplotypes on Transcriptional Regulation and Warfarin DoseNew England Journal of Medicine, 2005
- Highly multiplexed molecular inversion probe genotyping: Over 10,000 targeted SNPs genotyped in a single tube assayGenome Research, 2005
- Haploview: analysis and visualization of LD and haplotype mapsBioinformatics, 2004
- The International HapMap ProjectNature, 2003
- Multiplexed genotyping with sequence-tagged molecular inversion probesNature Biotechnology, 2003